Australia is experience potentially transformative medication for weight issues: Retatrutide. The dual molecule – acting on both GLP-1 and GIP receptors – demonstrates promising results in global research, indicating meaningful drops in BMI. While approval hasn't occurred with Australian regulators, several people struggling weight-related heal